Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney Disease
Clinical trial NCT05021731 · UNKNOWN
Trial details
- NCT number
- NCT05021731
- Sponsor
- Miguel Santín
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-20
- Primary completion
- 2025-04-30
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.